Two Chinese randomized trials found functional benefits from thrombectomy for mild or later-presenting strokes, alongside safety concerns that need further study.
Endovascular Therapy Eyed For Milder Strokes, Later Time Window
Browsing Category
Medical Science
222 posts
Chinese Drug Shows Benefit In HER2-Low Breast Cancer
A phase III trial in China found longer progression-free survival with trastuzumab rezetecan than chemotherapy, while severe side effects were more frequent.
AI Analysis Of CT Scans Finds 42.9% Of Patients Have Coronary Inflammation
A Biograph study found elevated coronary inflammation in 42.9% of asymptomatic, low-risk participants, but its clinical significance remains unproven.
Psilocybin Tied To Lower Inflammation In Parkinson’s Trial
A nonrandomized study of 12 people with Parkinson’s found lower inflammation markers after psilocybin, but larger controlled trials are needed.
ADHD Tied To Higher Mortality Risk
A review of 19 studies involving nearly 16 million people linked ADHD to higher mortality. A medication association was based on only three studies.
Your Age May Not Tell The Whole Story About Your Health, But Your Blood Could
A study of 18,476 people linked blood metabolite-based aging measures with chronic disease and mortality risk, but did not establish causation.
Fortell Expands Prescription AI Hearing Aids To More Than 30 States
Fortell says its prescription AI hearing aids are now available in more than 30 states through new clinics and remote audiology appointments.
Brain Cells Meant To Protect Us May Be Fueling Cognitive Decline
Human brain tissue and mouse experiments link reduced NRF2 activity in myelin-producing cells with nerve-fiber damage and age-related cognitive decline.
Fast-Acting Pill Reduces Heartburn Frequency In Non-Erosive Reflux Disease
In a 783-person U.S. phase III trial, tegoprazan increased heartburn-free days versus placebo through four weeks in non-erosive reflux disease.
Deaths Halt Trial Of Hemodialysis For Acute Kidney Injury
A French ICU trial stopped early after initial intermittent hemodialysis was linked to higher 90-day mortality than continuous therapy for acute kidney injury.
